Multiple Assemblies exist for SMTL entry 5se0
CRYSTAL STRUCTURE OF HUMAN PHOSPHODIESTERASE 10 IN COMPLEX WITH c1(cc(nn1CCO)c2ccccn2)NC(c3nc(ccc3Nc4cncnc4)C5CC5)=O, micromolar IC50=0.002253; X-RAY DIFFRACTION 2.01 Å

SMTL ID
5se0.1
Ligands
ZINC ION; MAGNESIUM ION; 6-cyclopropyl-N-[1-(2-hydroxyethyl)-3-(pyridin-2-yl)-1H-pyrazol-5-yl]-3-[(pyrimidin-5-yl)amino]pyridine-2-carboxamide
Polypeptides
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
Oligo-state
monomer
SMTL ID
5se0.2
Ligands
ZINC ION; MAGNESIUM ION; 6-cyclopropyl-N-[1-(2-hydroxyethyl)-3-(pyridin-2-yl)-1H-pyrazol-5-yl]-3-[(pyrimidin-5-yl)amino]pyridine-2-carboxamide
Polypeptides
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
Oligo-state
monomer
SMTL ID
5se0.3
Ligands
ZINC ION; MAGNESIUM ION; 6-cyclopropyl-N-[1-(2-hydroxyethyl)-3-(pyridin-2-yl)-1H-pyrazol-5-yl]-3-[(pyrimidin-5-yl)amino]pyridine-2-carboxamide
Polypeptides
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
Oligo-state
monomer
SMTL ID
5se0.4
Ligands
ZINC ION; MAGNESIUM ION; 6-cyclopropyl-N-[1-(2-hydroxyethyl)-3-(pyridin-2-yl)-1H-pyrazol-5-yl]-3-[(pyrimidin-5-yl)amino]pyridine-2-carboxamide
Polypeptides
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
Oligo-state
monomer